SFDA warned consumers of using the following batches: (0513011-0514005-0515006) for the preparation OMAFEN Drugs 400 mg tablets (OMAFEN 400 mg Tablet) which is preduced by the National Company for Pharmaceutical Industries, Sultanate of Oman, due to lack of matching those batches physical specifications and it have presence of small aluminum chips in the product bar.
SFDA explained in a statement, it proved that after checking 2 batches of product (0513011, 0514005), when it entered Saudi market, and therefore SFDA obligated all distribution agents to stop these batches and pull them from of all sales outlets.
SFDA recommended consumers to avoid using these batches, referring to the availability of several alternatives for this drug.
SFDA called consumers to inform the National Center for vigilance and pharmaceutical safety in case of any side effects from the drugs and so on Phone: 0112038222 Ext: 2340.2354, 5721.2356, 2057662-011 or fax, or e-mail: